Liver transplantation for hereditary transthyretin amyloidosis

Liver Transplantation

Volumn 6, Issue 3, 2000, Pages 263-276

  Suhr, Ole B ^a   Herlenius, Gustav ^b   Friman, Styrbjörn ^c   Ericzon, Bo Göran ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

AMINO ACID SUBSTITUTION; AMYLOIDOSIS; ENDEMIC DISEASE; GENE MUTATION; GENETIC VARIABILITY; HEREDITY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SWEDEN;

EID: 0034126224     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/lv.2000.6145     Document Type: Review

References (118)

1. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983;116:880-888.
2. Christmanson L, Betsholtz C, Gustavsson A, Johansson B, Sletten K, Westermark P. The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis. FEBS-Lett 1991;281:177-180.
3. Torres MF, Almeida MR, Saraiva MJ. TTR exon scanning in peripheral neuropathies. Neuromuscul Disord 1995;5:187-191.
4. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997;336:466-473.
5. Andrade C. A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-427.
6. Andersson R. Familial amyloidosis with polyneuropathy: A clinical study based on patients living in northern Sweden. Acta Med Scand 1976;198(suppl 590):1-76.
7. Coutinho P, Martins da Silva A, Kopes Lima J, Resende Barbosa A. Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In: Glenner G, Pinho e Costa P, Folcao de Freitas A (eds). Amyloid and amyloidosis. Amsterdam: Excerpta Medica, 1980:88-98.
8. Araki S, Kurihara T, Tawara S, Kuribayashi T. Familial amyloidotic polyneuropathy in Japanese. In: Glenner GG, Pinho e Costa P, de Freitas AF (eds). Amyloid and amyloidosis. Portugal: Excerpta Medica, 1979:67-77.
9. Sandgren O, Drugge U, Holmgren G, Sousa A. Vitreous involvement in familial amyloidotic neuropathy: A genealogical and genetic study. Clin Genet 1991;40:452-460.
10. Olofsson B-O. Cardiac involvement in familial amyloidosis with polyneuropathy. Int J Cardiol 1983;4:71-73.
11. Eriksson P, Eriksson A, Backman C, Hofer PA, Olofsson BO. Highly refractile myocardial echoes in familial amyloidosis with polyneuropathy. A correlative echocardiographic and histopathological study. Acta Med Scand 1985;217:27-32.
12. Eriksson P, Boman K, Jacobsson B, Olofsson BO. Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia. Acta Anaesthesiol Scand 1986;30:317-320.
13. de Freitas A. The heart in Portuguese amyloidosis. Postgrad Med J 1986;62:601-605.
14. Steen L, Ek B. Familial amyloidosis with polyneuropathy. A long term follow up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 1984;214:387-397.
15. Steen L, Wahlin A, Bjerle P, Holm S. Renal function in familial amyloidosis with polyneuropathy. Acta Med Scand 1982;212: 233-236.
16. Ikeda S, Yanagisawa N, Hongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL amyloidosis. J Neurol Sci 1987;79:129-139.
17. Olofsson B-O, Suhr O, Niklasson U, Wiklund U, Bjerle P, Beckman A. Assessment of autonomic nerve function in familial amyloidotic polyneuropathy: A clinical study based on spectral analysis of heart rate variability. Amyloid 1994;1:138-142.
18. Fonseca C, Ceia F, Carvalho A, Morais H, Sá-Nogueira J, Ferreira P, et al. Assessment of autonomic dysfunction in familial amyloidotic polyneuropathy: A challange [abstract]. Neuromuscul Disord 1996;6(suppl):S48A.
19. Carvalho MJ, Man in't Veld AJ, Costa O, Freitas J, Puig J, de Freitas F. Spectral analysis of the heart rate as an assessment of autonomic function in familial amyloid polyneuropathy. J Hypertens Suppl 1991;9:62-63.
20. Ando Y, Araki S, Shimoda O, Kano T. Role of autonomic nerve function in patients with familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule hydrography, and cardiographic R-R interval. Muscle Nerve 1992;15:507-512.
21. Nakata T, Shimamoto K, Yonekura S, Kobayashi N, Sugiyama T, Imai K, et al. Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: Detection with iodine-123-MIBG. J Nucl Med 1995;36:1040-1042.
22. Ciulla TA, Tolentino F, Morrow JF, Dryja TP. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation. Surv Ophthalmol 1995;40:197-206.
23. Andersson R, Kassman T. Vitreous opacities in primary familial amyloidosis. Acta Ophthalmol Copenh 1968;46:441-447.
24. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: Long term follow up. Br J Ophthalmol 1997;81:295-298.
25. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173-196.
26. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235:479-485.
27. Tashima K, Suhr OB, Ando Y, Holmgren G, Yamashita T, Obayashi K, et al. Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met) - Comparison of Swedish and Japanese patients. Amyloid 1999;6:124-129.
28. Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid 1996;3:44-56.
29. Takahashi N, Ueno S, Uemichi T, Fujimura H, Yorifuji S, Tarui S. Amyloid polyneuropathy with transthyretin Arg50 in a Japanese case from Osaka. J Neurol Sci 1992;112:58-64.
30. Ueno S, Fujimura H, Yorifuji S, Nakamura Y, Takahashi M, Tarui S, et al. Familial amyloid polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred. Brain 1992;115:1275-1289.
31. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997; 64:74-80.
32. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis. Transplantation 1998;66:229-233.
33. Ranlov I, Alves I, Ranlöv PJ, Husby G, Costa PP, Saraiva M. A Danish kindred with familial amyloid cardiomyopathy revisited: Identification of a mutant transthyretin-methionine 111 variant in serum from patients and carriers. Am J Med 1992;93:3-8.
34. Fredriksen T, Gotzsche H, Harboe N, Kiaer W, Mellemgaard K. Familial primary amyloidosis with severe amyloid heart disease. Am J Med 1962;33:325-348.
35. 30). Clin Genet 1991;40:242-246.
36. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113-1116.
37. Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995;60:933-938.
38. Svendsen IH, Mortensen SA, Kirkegaard P, Suhr OB, Tashima K, Ohlsson P-I, et al. Combined heart and liver transplantation for familial amyloid cardiomyopathy (ATTR Leu111Met) [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;P66:76.
39. Harrison RF, Hawkins PN, Roche WR, MacMahon RF, Hubscher SG, Buckels JA. 'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis. Gut 1996;38:151-152.
40. Zeldenrust S, Gertz M, Uemichi T, Bjornsson J, Benson MD. Orthotopic liver transplantation for hereditary fibrinogen amyloidosis [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;O44:41.
41. Gillmore JD, Booth DR, Rela M, Heaton ND, Williams RS, Harrison P, et al. Curative hepatorenal transplantation for systemic amyloidosis associated with fibrinogen-chain Glu526Val in an English family. In: Kyle RA, Gertz MA (eds). Amyloid and amyloidosis. New York: Parthenon, 1999:336-338.
42. Nakazato M, Shiomi K, Miyazato M, Matsukura S. Type I familial amyloidotic polyneuropathy in Japan. Intern Med 1992;31:1335-1338.
43. Conceicao I, Dias M, de Carvalho M, Saraiva MJ, Sales Luis ML. Clinical variability of familial amyloidotic polyneuropathy type 1 in late onset families [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;P29:58.
44. 119 [abstract]. J Rheumatol 1993;20:179A.
45. Sousa A, Ferreira C, Barros J, Coelho T. Change in paradigm of Portuguese FAP patients: In the last 12 years, onset becomes later and new families come from distinct areas [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;O26:30.
46. 30 carriers in Northern Sweden: Discrepancy between carrier frequency and prevalence rate. J Med Genet 1994;31:351-354.
47. Holmgren G, Ando Y, Wikström L, Rydh A, Suhr O. Discordant symptoms in monozygotic twins with familial amyloidotic polyneuropathy (FAP) (TTR Met 30). Amyloid 1997;4:178-180.
48. Munar-Ques M, Pedrosa JL, Coelho T, Gusmao L, Seruca R, Amorim A, et al. Two pairs of proven monozygotic twins discordant for familial amyloid neuropathy (FAP) TTR Met 30. J Med Genet 1999;36:629-632.
49. Holmgren G, Bergstrom S, Drugge U, Lundgren E, Nording Sikstrom C, Sandgren O, et al. Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1992;41: 39-41.
50. Ikeda S, Nakano T, Yanagisawa N, Nakazato M, Tsukagoshi H. Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuropathy. Eur Neurol 1992;32:308-313.
51. Suhr OB, Ando Y, Holmgren G, Wikström L, Friman S, Herlenius G, et al. Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patients' survival. Transpl Int 1998;11(suppl 1):S160-S163.
52. Ikeda S, Takai Y, Yanagisawa N, Matsunami H, Hashikura Y, Ikegami T, et al. Partial liver transplantation from living donors in familial amyloid polyneuropathy. Amyloid 1997;4:18-23.
53. Monteiro E, Perdigoto R, Furtado AL. Liver transplantation for familial amyloid polyneuropathy. Hepatogastroenterology 1998;45:1375-1380.
54. Parilla P, Ramirez P, Bueno F, Robles R, Acosta F, Miras M, et al. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy. Br J Surg 1995;82:825-828.
55. Adams D, Samuel D, Goulon-Goeau C, Costa P, Nakazato M, Mentral S, et al. Evaluation of liver transplantation in patients with familial amyloidotic polyneuropathy: Study in cohort of 29 patients [abstract]. Presented at the 8th Congress of the European Society for Organ Transplantation, Budapest, Hungary, September 2-6, 1997;P18.
56. Bergethon P, Sabin T, Lewis D, Simms R, Cohen A, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996;47:944-951.
57. Lewis W, Skinner M, Jenkins R. Report on 24 patients with liver transplantation for FAP in the United States [abstract]. Neuromuscul Disord 1996;6:77A.
58. Skinner M, Lewis W, Jones L, Kasirsky J, Kane K, Ju S-T, et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994;120:133-134.
59. Suhr O, Holmgren G. Difficulties in clinical diagnosis and prediction of outcome in patients with the transthyretin Met 30 mutation. Report of two cases. Amyloid 1995;2:179-182.
60. Suhr OB, Danielsson A, Rydh A, Nyhlin N, Hietala SO, Steen L. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig Dis Sci 1996;41:1909-1914.
61. Parilla P, Ramirez P, Andreu LF, Bueno SF, Robles R, Miras M, et al. Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I. Transplantation 1997;64: 646-663.
62. Tomé.L, Mota O, Mestre A, Ferrão J, Peridigoto R, Furtado L. Liver transplantation for familial amyloidotic polyneuropathy. Evolution of peripheral neuropathy [abstract]. Gut 1996;39: 98A.
63. Sales-Luis ML. Clinical/EMG evaluation of therapeutics in FAP including liver transplantation [abstract]. Eur J Neurol 1999;6(suppl 3):S180A.
64. Ando Y, Suhr OB. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998;5:288-300.
65. Suhr OB, Wiklund U, Eleborg L, Ando Y, Backman C, Birgersdotter V, et al. Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy. Transplantation 1997;63:675-679.
66. Steen L, Holmgren G, Suhr O, Wikström L, Groth C-G, Ericzon BG. World-wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid 1994;1:138-142.
67. Eleborg L, Suhr O, Gunnarsson L. Familial amyloidotic polyneuropathy (FAP) - Cardiac and circulatory function during anesthesia for liver transplantation. Amyloid 1997;4: 24-32.
68. Viana JS, Bento C, Vieira H, Neves S, Seco C, Elvas L, et al. Haemodynamics during liver transplantation in familial amyloidotic polyneuropathy: Study of the intraoperative cardiocirculatory data of 50 patients. Rev Port Cardiol 1999;18:689-697.
69. Ducla Soares J, Breitenfeld L, Povoa P, Ferreira M, Carvalho M, Alves M, et al. Plasma catecholamines and postural hypotension in familial amyloidotic polyneuropathy of the Portuguese type. Clin Auton Res 1991;1:271-274.
70. Hagerman I, Berglund M, Ericzon B-G, Eleborg L. Total pharmacologic autonomic blockade (TAB) reveals severe autonomic imbalance of heart rate variablity (HRV) in familial amyloidotic polyneuropathy [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;O10:22.
71. Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999;26:416-424.
72. Carvalho M, Veld Mi, Boomsma F, Costa O, Freitas J, Puig J, et al. L-treo-dihydroxyphenylserine for treatment of orthostatic hypotension in familial amyloidotic polyneuropathy. J Hypertension 1994;12(suppl 3):S54.
73. Suzuki T, Azuma T, Araki S, Ikegawa S, Kito S, Matsubayashi H, et al. Treatment of autonomic dysfunction with L-treo-3,4-dihydroxyphenylserine in patients with familial amyloidotic polyneuropathy: A multicenter study. In: Isobe T, Araky S, Uchino F, Kito S, Tsubura E (eds). Amyloid and amyloidosis. New York: Plenum, 1988:851-856.
74. Wikström L, Bjerle P, Boman K, Holmgren G, Steen L. L-treo-DOPS treatment of orthostatic hypotension in Swedish patients with familial amyloidotic polynbeuropathy (TTR-met30). Amyloid 1996;3:162-165.
75. Viana JS, Bento C, Vieira H, Neves S, Furtardo AL. Anaesthetic management of the patient with familial amyloidotic polyneuropathy - Experience of 26 liver transplantations [abstract]. Neuromuscul Disord 1996;6:72A.
76. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: Correlation with echocardiographic abnormalities. J Am Coll Cardiol 1984;3:107-113.
77. Tallgren M, Hockerstedt K, Makinen J, Kirvela M, Lindgren L. Cardiac evaluation of liver transplant recipients: QT dispersion in electrocardiogram. Clin Transplant 1996;10:408-413.
78. Stangou AJ, Booth DR, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy. In: Kyle RA, Gertz MA (eds). Amyloid and amyloidosis. New York: Parthenon, 1999:330-332.
79. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998;65:918-925.
80. Lobato L, Beirao I, Guimaraes SM, Droz D, Guimaraes S, Grunfeld JP, et al. Familial amyloid polyneuropathy type I (Portuguese): Distribution and characterization of renal amyloid deposits. Am J Kidney Dis 1998;31:940-946.
81. Andersson R, Bjerle P. Studies of urinary bladder dysfunction in amyloidosis with polyneuropathy. Acta Med Scand 1975;197: 117-123.
82. Villaplana HG, Rosino HE, Cubillana LP, Asensio EL, Pertusa MP, Albeceta PM. Corino-Andrade disease (familial amyloidotic polyneuropathy type I) in Spain: Urological and andrological disorders. Neurourol Urodyn 1997;16:55-61.
83. Rydh A, Suhr O, Hietala S-O, Riklund Åström K, Pepys MB, Hawkins PN. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: Regression of visceral amyloid following liver transplantation. Eur J Nucl Med 1998;25: 709-713.
84. El-Salhy M, Nyhlin N, Ando Y, Suhr O. The neuroendocrine system and gastrointestinal complications in patients with familial amyloidosis and polyneuropathy. Scand J Gastroenterol 1997;32:849-854.
85. El-Salhy M, Suhr O. Endocrine cells in rectal biopsies from patients with familial amyloidotic polyneuropathy. Scand J Gastroenterol 1996;31:68-73.
86. El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994;35:1413-1418.
87. Nyhlin N, Anan I, El-Salhy M, Ando Y, Suhr OB. Endocrine cells in the upper gastrointestinal tract in relation to gastrointestinal dysfunction in patients with familial amyloidotic polyneuropathy. Amyloid 1999;6:192-198.
88. Anan I, El-Salhy M, Ando Y, Forsgren S, Nyhlin N, Terazaki H, et al. Colonic enteric nervous system in patients with familial amyloidotic polyneuropathy. Acta Neuropathol 1999; 98:48-54.
89. Ferrão J, Tomé L, Mota O, Perdigoto R, Viana J, Furtado E, et al. Liver transplantation in FAP patients - The need of reliable criteria for patient exclusion [abstract]. Presented at New Dimensions in Transplantation, Florence, Italy, February 16-19, 1998;266.
90. Kruger M, Altland K, Linke RP, Maschek H, Ringe B, Oehler G, et al. Liver transplantation in familial amyloid polyneuropathy. Case report and review of the literature [German]. Internist (Berl) 1997;38:692-700.
91. Ramirez P, DeMingo P, Andreu M, Hernández Q, Munitiz V, Rios A, et al. Long-term results of liver transplantation in four siblings from the same ramily with familial amyloidotic polyneuropathy type ITTR ALA-71. Transplant Proc 1999;31: 2489-2490.
92. Garcia-Herola A, Prieto M, Pascual S, Berenguer M, Lopez-Viedma B, Mir J, et al. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg 1999;5:246-248.
93. Furtado A, Tome L, Oliveira FJ, Furtado E, Viana J, Perdigoto R. Sequential liver transplantation. Transplant Proc 1997;29: 467-468.
94. Furtado L, Oliveira F, Furtado E, Geraldes B, Reis A, Viana J, et al. Maximum sharing of cadaver liver grafts: Composite split and domino liver transplants. Liver Transpl Surg 1999;5:157-158.
95. Schmidt HH, Nashan B, Propsting MJ, Nikazato M, Flemming P, Kubicka S, et al. Familial amyloidotic polyneuropathy. Domino liver transplantation. J Hepatol 1999;30:293-298.
96. Stangou AJ, Heaton ND, Rela M, Pepys MB, Hawkins PN, Williams R. Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy. Transplantation 1998;65:1496-1498.
97. Furtado AJL, Oliveira FJ, Geraldes JB, Furtado E, Viana J, Bento C, et al. Early results of sequential transplantation using familial amyloidotic polyneuropathy (FAP) patients' livers [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;P51:69.
98. Bittencourt PL, Leitao RMC, Cancado ERL, Farias AQ, Almeida MD, Baia CES, et al. Investigation of amyloid deposition in gastrointestinal biopsies of patients submitted to domino liver transplantation [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;O33:34.
99. Söderdahl G, Suhr O, Holmgren G, Herlenius G, Ericzon B-G. Reply to a letter to the editor. Liver Transpl Surg 1996;2:332-333.
100. Anan I, El-Salhy M, Nyhlin N, Suhr OB. Liver transplantation restores the endocrine cells in patients with familial amyloidotic polyneuropathy [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999; O30:33.
101. Jonsén E, Suhr O, Athlin E, Wikström L. Quality of life after liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid 1996;3:124-129.
102. Jonsen E, Suhr OB, Athlin E. Quality of life before and after liver transplantation in patients with familial amyloidotic polyneuropathy [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;P46:66.
103. Libbey C, La Valley M, Murakami A, Katz S, Lewis D, Skinner M. Familial amyloidosis, 7 years clinical experience and liver transplant quality of life assessments [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;O47:43.
104. Lopes A, Branco M, Coelho T, Sousa A, Caetano-Pereira M. Psycho-social and familial impact of liver transplant in patients with familial amyloid polyneuropathy (FAP) [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;P50:68.
105. Ericzon BG, Suhr O, Broome U, Holmgren G, Duraj F, Eleborg L, et al. Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplant Proc 1995;27: 1233.
106. Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, Ikegami T, et al. Peripheral nerves regenerated in familial amyloid polyneuropathy after liver transplantation. Ann Intern Med 1997;127:618-620.
107. Takei Y, Ikeda S, Hashikura Y, Ikegami T, Kawasaki S. Partial-liver transplantation to treat familial amyloid polyneuropathy: Follow-up of 11 patients. Ann Intern Med 1999;131: 592-595.
108. Bentes C, Sales Luis ML, de Carvalho M. Liver transplantation in familial amyloidotic polyneuropathy: Clinical and neurophysiological follow-up of 27 patients [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;O43:41.
109. Tashima K, Ando Y, Terazaki H, Yoshimatsu S, Suhr OB, Obayashi K, et al. Outcome of liver transplantation for transthyretin amyloidosis: Follow-up of Japanese familial amyloidotic polyneuropathy patients. J Neurol Sci 1999;171: 19-23.
110. Fournier B, Giostra E, Mentha G, Huber O, Hadengue A, Morel P. Orthotopic liver transplantation for familial Portuguese amyloidosis [Swiss]. Schweiz Med Wochenschr Suppl 1997;89:250-255.
111. Suhr OB, Wiklund U, Ando Y, Ando E, Olofsson BO. Impact of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy. J Intern Med 1997;242:225-229.
112. Carvalho MJ, van den Meiracker AH, Boomsma F, Freitas J, Man in't Veld AJ, Costa O, et al. Role of sympathetic nervous system in cyclosporine-induced rise in blood pressure. Hypertension 1999;34:102-106.
113. Lang K, Wikstrom L, Tashima K, Rydh A, Suhr OB. Malabsorption and bacterial small bowel contamination after liver transplantation for familial amyloidotic polyneuropathy (FAP ATTR V30M) [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999; P49:68.
114. Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation [letter]. Transplantation 1996;62:1037-1038.
115. Munar-Ques M, Salva-Ladaria P, Mulet-Perera M, Sole M, Saraiva MJ. Vitreous amyloid in a patient with FAT TTR Met 30 after liver transplantation. In: Kyle RA, Gertz MA (eds). Amyloid and amyloidosis. New York: Parthenon, 1999:339-341.
116. Ando Y, Tanaka Y, Nakazato M, Ericzon BG, Yamashita T, Tashima K, et al. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem Biophys Res Commun 1995;211:354-358.
117. Gillmore JD, Stangou AJ, O'Grady J, Dabies MH, Rela M, Heaton ND, et al. Possible progressive CNS amyloidosis following liver transplantation for FAP [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;P61:74.
118. Stangou AJ, Gillmore JD, Booth DJ, O'Grady J, Rela M, Heaton ND, et al. Cardiac morbidity and mortality in OLT for non-Met30 TTR associated FAP [abstract]. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå, Sweden, June 3-5, 1999;O29:32.